相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
S. Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Advances in clinical trial design for development of new TB treatments: A call for innovation
Christian Lienhardt et al.
PLOS MEDICINE (2019)
Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine
Kristina M. Brooks et al.
CLINICAL INFECTIOUS DISEASES (2018)
Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children
A. J. Garcia-Prats et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
State-of-the-Art Review of HIV-TB Coinfection in Special Populations
Ethel D. Weld et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Two decades of off-label prescribing in children: a literature review
Shamala Balan et al.
WORLD JOURNAL OF PEDIATRICS (2018)
Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis
Yohhei Hamada et al.
LANCET HIV (2018)
Increasing the Participation of Pregnant Women in Clinical Trials
Katrina Heyrana et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Exposure to Latent Tuberculosis Treatment during Pregnancy The PREVENT TB and the iAdhere Trials
Ruth N. Moro et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study
Nicole Salazar-Austin et al.
CLINICAL INFECTIOUS DISEASES (2018)
Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries
Anthony D. Harries et al.
DIAGNOSTICS (2018)
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
Martin J. Boeree et al.
LANCET INFECTIOUS DISEASES (2017)
Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda
Deanna Saylor et al.
NEUROLOGY (2017)
A Community Perspective on the Inclusion of Pregnant Women in Tuberculosis Drug Trials
Lindsay McKenna et al.
CLINICAL INFECTIOUS DISEASES (2017)
Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa
Muhammad Osman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa
Paolo Denti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
Amita Gupta et al.
CLINICAL INFECTIOUS DISEASES (2016)
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
Martin J. Boeree et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention
Anthony T. Podany et al.
CLINICAL INFECTIOUS DISEASES (2015)
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
Scott R. Evans et al.
CLINICAL INFECTIOUS DISEASES (2015)
Special Populations and Pharmacogenetic Issues in Tuberculosis Drug Development and Clinical Research
Helen McIlleron et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
Sharon Nachman et al.
LANCET INFECTIOUS DISEASES (2015)
Pharmacokinetics of Efavirenz and Treatment of HIV-1 Among Pregnant Women With and Without Tuberculosis Coinfection
Kelly E. Dooley et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Designing Drug Trials: Considerations for Pregnant Women
Jeanne S. Sheffield et al.
CLINICAL INFECTIOUS DISEASES (2014)
Tuberculosis in children
Ben J. Marais
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2014)
Pregnancy and Infection
Athena P. Kourtis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pregnancy Differentially Impacts Performance of Latent Tuberculosis Diagnostics in a High-Burden Setting
Jyoti S. Mathad et al.
PLOS ONE (2014)
Tuberculosis in pregnancy: an estimate of the global burden of disease
Jordan Sugarman et al.
LANCET GLOBAL HEALTH (2014)
Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps
Jyoti S. Mathad et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Effect of HIV Infection, Immunodeficiency, and Antiretroviral Therapy on the Risk of Hepatic Dysfunction
William J. Towner et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Reframing the Framework: Toward Fair Inclusion of Pregnant Women as Participants in Research
Anne Drapkin Lyerly et al.
AMERICAN JOURNAL OF BIOETHICS (2011)
Tuberculosis Drug Development Ensuring People Living with HIV Are Not Left Behind
Anne F. Luetkemeyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study
Mark P. Nicol et al.
LANCET INFECTIOUS DISEASES (2011)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
Julia Dunne et al.
PEDIATRICS (2011)
Drug interactions involving combination antiretroviral therapy and other anti-infective agents: Repercussions for resource-limited countries
Kelly E. Dooley et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Treatment of multidrug-resistant tuberculosis during pregnancy: A report of 7 cases
S Shin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Physiologic changes in pregnancy and their effect on drug disposition
MC Frederiksen
SEMINARS IN PERINATOLOGY (2001)
分享论文
